Considerable variations have been observed in the postnatal management and outcomes of hemolytic disease of the fetus and ...

A recent study showed limited data exist on the risks associated with anti-G during pregnancy, including the development of ...

A recent review showed Rhesus D (RhD)-negative red blood cell (RBC) products should be the first choice for women who require ...

In pregnancies at risk of hemolytic disease of the fetus and newborn (HDFN), amniocentesis is used to identify the fetus’s ...

A case report described an infant with concurrent HDFN and SMA who was succesfully treated with an onasemnogene abeparvovec infusion.

Learn about why delayed hemolysis occurs, how it can affect newborns diagnosed with HDFN and how it can be treated.

Erin Collins was 37 weeks and four days pregnant in 2019 when—after an agonizing 32 hours in labor—she gave birth to B.B., ...

Learn more about what Rh immunoglobulin (RhIG) treatment is, how it is administered and how it works to prevent HDFN.

A recently published opinion piece stated there is a significant need for consensus in how to manage and treat HDFN across ...

Learn more about how antibody titers affect HDFN, how they are tested and what can happen if antibody titer levels are too ...

A recent study showed that a history of blood transfusions for alloimmunized pregnancies may not affect patient outcomes. The authors aimed to assess whether a history of previous blood transfusions ...

A recent study found that while 80% of participants with multiple antibodies underwent intrauterine transfusions, only 34.3% of those with one antibody required the procedure. The retrospective study ...